Literature DB >> 15690400

A kindred with MYH-associated polyposis and pilomatricomas.

Silvana Baglioni1, German Melean, Francesca Gensini, Marco Santucci, Marco Scatizzi, Laura Papi, Maurizio Genuardi.   

Abstract

MYH-associated polyposis (MAP) is a recently described autosomal recessive form of familial adenomatous polyposis (FAP) associated with susceptibility to colorectal carcinoma (CRC). MAP is caused by biallelic inactivating mutations of the MYH gene, a component of the base excision repair (BER) machinery, whose dysfunction leads to an increase in the rate of G > T transversions following DNA oxidative damage. MAP patients can present with either classic or attenuated polyposis. However, the MAP colonic and extracolonic phenotype has yet to be defined. We report on two siblings, born from consanguineous parents, who were found to be homozygotes for an MYH frameshift mutation. The propositus presented with a low number of colonic lesions and an early-onset CRC. Both siblings had a history of pilomatricomas, benign tumors derived from hair follicles, in childhood. The findings presented provide further evidence of phenotypic variability in MAP, and suggest that multiple pilomatricomas may be a useful cutaneous marker of MAP. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15690400     DOI: 10.1002/ajmg.a.30585

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

1.  Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer.

Authors:  Aung Ko Win; Sean P Cleary; James G Dowty; John A Baron; Joanne P Young; Daniel D Buchanan; Melissa C Southey; Terrilea Burnett; Patrick S Parfrey; Roger C Green; Loïc Le Marchand; Polly A Newcomb; Robert W Haile; Noralane M Lindor; John L Hopper; Steven Gallinger; Mark A Jenkins
Journal:  Int J Cancer       Date:  2011-04-08       Impact factor: 7.396

2.  Papillary thyroid cancer in a patient with MUTYH-associated polyposis (MAP).

Authors:  Muhammad Ali Pervaiz; Amanda Eppolito; Karen Schmidt
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

3.  Inter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair research.

Authors:  Zachary D Nagel; Isaac A Chaim; Leona D Samson
Journal:  DNA Repair (Amst)       Date:  2014-04-26

4.  Biallelic MYH germline mutations as cause of Muir-Torre syndrome.

Authors:  Carmen Guillén-Ponce; Adela Castillejo; Víctor M Barberá; J Carlos Pascual-Ramírez; Encarnación Andrada; M Isabel Castillejo; Carla Guarinós; M J Molina-Garrido; Alfredo Carrato; J L Soto
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

5.  Genetic Counselor Practices Involving Pediatric Patients with FAP: an Investigation of their Self-Reported Strategies for Genetic Testing and Hepatoblastoma Screening.

Authors:  Caitlin E Lawson; Thomas M Attard; Hongying Dai; Seth Septer
Journal:  J Genet Couns       Date:  2016-12-03       Impact factor: 2.537

6.  Sebaceous adenomas in an MYH associated polyposis patient of Indian (Gujarati) origin.

Authors:  Vadakke Kanakath Ajith Kumar; June Anne Gold; Eleanor Mallon; Shyamala Thomas; Shirley V Hodgson
Journal:  Fam Cancer       Date:  2007-09-15       Impact factor: 2.375

Review 7.  Diseases associated with defective responses to DNA damage.

Authors:  Mark O'Driscoll
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

Review 8.  Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies.

Authors:  Manny D Bacolod; Gunter S Schemmann; Sarah F Giardina; Philip Paty; Daniel A Notterman; Francis Barany
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

9.  MUTYH Associated Polyposis (MAP).

Authors:  M L M Poulsen; M L Bisgaard
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

Review 10.  Familial adenomatous polyposis.

Authors:  Elizabeth Half; Dani Bercovich; Paul Rozen
Journal:  Orphanet J Rare Dis       Date:  2009-10-12       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.